Shankar Dutt

I am a nanobiotechnologist, materials scientist, and biomedical engineer pioneering AI-integrated point-of-care diagnostics at the intersection of nanotechnology, machine learning, and clinical medicine. With a strong foundation in physics and expertise in nanomaterials fabrication, I develop novel biosensing platforms that push the boundaries of early disease detection.

My research program develops solid-state nanopore biosensors for early detection of neurodegenerative diseases and cancer, achieving label-free protein identification with 88.7% accuracy through innovative fusion of single-molecule sensing and machine learning. This work has been featured in over 100 international media outlets.

With demonstrated success in translational research, including partnerships with Thaum Pty Ltd for early diagnostics of Alzheimer's and collaborations with ACT Health and Rio-Tinto on environmental health monitoring, I bridge fundamental biophysics and nanoscience with biomedical applications. My materials science background enables precise control over nanopore fabrication using ion irradiation, chemical etching, and advanced thin-film deposition techniques.